Head and neck cancer treatment protocols still lack well-established biomarkers of prognostic and predictive value. It is well known that human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancers are ...
Lévay, Magdolna; Bartos, Balázs Ádám; Ligeti, Erzsébet(2013)
p190RhoGAP is a GTPase-activating protein (GAP) known to regulate actin cytoskeleton dynamics by decreasing RhoGTP levels through activation of the intrinsic GTPase activity of Rho. Although the GAP domain of p190RhoGAP ...
Wang SP; Iring, András; Strilic B; Juarez JA; Kaur H(2015)
Elevated blood pressure is a key risk factor for developing cardiovascular diseases. Blood pressure is largely determined by vasodilatory mediators, such as nitric oxide (NO), that are released from the endothelium in ...
Saft L; Karimi M; Ghaderi M; Matolcsy, András; Mufti GJ; Kulasekararaj A; Gohring G; Giagounidis A; Selleslag D; Muus P; Sanz G; Mittelman M; Bowen D; Porwit A; Fu T; Backstrom J; Fenaux P; MacBeth KJ; Hellstrom-Lindberg E(2014)
Del(5q) myelodysplastic syndromes defined by the International Prognostic Scoring System as low- or intermediate-1-risk (lower-risk) are considered to have an indolent course; however, recent data have identified a subgroup ...
The effect of PACAP38 on the LH surge and ovulation was compared
with that of PACAP27 and VIP in the same model. The peptides
were administered intracerebroventricularly before the critical
period of the proestrous ...
Pituitary adenylate cyclase activating polypeptide (PACAP) and
its close relative vasoactive intestinal polypeptide (VIP) were
demonstrated in the anterior pituitary gland. The cells which
exhibited PACAP immunoreactivity ...
This article reviews various ophthalmic diseases in the most famous historical paintings. Sometimes, the ophthalmic diseases might also substantially affect the vision of artists and we can deduct from their paintings what ...
Aim: To investigate across multiple cycles the efficacy and safety of palonosetron in the prevention of chemotherapy-induced nausea and vomiting in pediatric cancer patients receiving highly or moderately emetogenic ...
BACKGROUND: Palonosetron has shown efficacy in the prevention of chemotherapy-induced nausea and vomiting in adults undergoing moderately or highly emetogenic chemotherapy. We assessed the efficacy and safety of palonosetron ...